The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Novavax, Inc. and Serum Institute of India Pvt. announced that the Thailand Food and Drug Administration (Thai FDA) has granted emergency use ...
read more
Wednesday, March 30, 2022
Mapi Pharma Ltd. announced that the company has been granted U.S. Patent No. 11,167,003 entitled: “Methods for suppressing or alleviating primary or ...
read more
The U.S. Food and Drug Administration announced it is requesting a total budget of $8.4 billion as part of the President's fiscal year (FY) 2023 ...
read more
Santhera Pharmaceuticals (and ReveraGen BioPharma, Inc announced the initiation of a rolling new drug application (NDA) submission to the FDA for ...
read more
Australian biotech company Noxopharm announced the FDA granted Orphan Drug Designation (ODD) to Veyonda®, its lead oncology drug candidate, for use in...
read more
Innovent Biologics, Inc. and Eli Lilly and Company announced that in light of both parties' shared commitment to continue bringing innovative ...
read more
Merck announced the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending ...
read more
Kaléo announced that the U.S. Food and Drug Administration (FDA) has approved its Naloxone Auto-injector 10 mg (NALOXONE HYDROCHLORIDE injection) ...
read more
Monday, February 28, 2022
Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) for...
read more
Friday, February 25, 2022
The FDA approved the first generic of Apokyn (apomorphine hydrochloride injection) drug cartridges to treat hypomobility “off” episodes (“end-of-dose ...
read more
Monday, February 14, 2022
Eli Lilly and Company announced an agreement with the U.S. government to supply up to 600,000 doses of investigational drug bebtelovimab for at least ...
read more
Monday, February 14, 2022
ProBioGen has announced a multi-product commercial license agreement with AstraZeneca to use the GlymaxX technology. Following evaluation of the ...
read more
Monday, February 14, 2022
The U.S. Food and Drug Administration took new steps aimed at fostering the development of non-addictive alternatives to opioids to manage acute pain ...
read more
Friday, February 11, 2022
Evofem Biosciences, Inc., announced that the U.S. Food and Drug Administration (FDA) has awarded "Qualified Infectious Disease Product" (QIDP) ...
read more
Tuesday, February 08, 2022
Teva Pharmaceuticals has reached an agreement with the Attorney General (AG) of Texas that settles the state’s and its subdivisions opioid-related ...
read more